Medicines for Malaria Venture (MMV) welcomes the resolution on accelerating the SDG targets for maternal health and child mortality. In malaria, most cases and deaths are found amongst under-5 children and pregnant women. MMV support the call of the Global Accelerator for Paediatric formulations network to prioritize development of child-friendly formulations. Commitments are also needed to improve and scale up existing tools for children and mothers, such as seasonal malaria chemoprevention, intermittent preventive treatments for pregnant women and, importantly, treatments against severe malaria. Novel approaches and tools are in development, including to address resistance to current tools, and with support they can contribute significantly to our joint effort to reduce children’s and mothers’ mortality, in line with the Yaoundé Declaration for accelerated malaria mortality reduction in Africa.